fluphenazine has been researched along with alpha 1-Antitrypsin Deficiency in 1 studies
alpha 1-Antitrypsin Deficiency: Deficiency of the protease inhibitor ALPHA 1-ANTITRYPSIN that manifests primarily as PULMONARY EMPHYSEMA and LIVER CIRRHOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Pak, SC | 1 |
| O'Reilly, LP | 1 |
| Benson, JA | 1 |
| Wang, Y | 1 |
| Hidvegi, T | 1 |
| Hale, P | 1 |
| Dippold, C | 1 |
| Ewing, M | 1 |
| Silverman, GA | 1 |
| Perlmutter, DH | 1 |
1 other study available for fluphenazine and alpha 1-Antitrypsin Deficiency
| Article | Year |
|---|---|
Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiency.
Topics: alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Animals; Animals, Genetically Modified; Antipsy | 2014 |